In April FESCA and the Scleroderma Society of Canada signed an agreement with Boehringer Ingelheim with the intention of working together to advance clinical research and improve awareness of systemic sclerosis (SSc) also known as scleroderma. Read more here. Because the Danish Scleroderma Association is a part of Fesca, and I am the international contact person […]